Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market
March 17, 2022
Host Chris Miglino interviews CFO Jim Heindlmeyer.
March 17, 2022
February 12, 2020
April 1, 2022
June 30, 2021
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.